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MMSEIn addition to cognitive impairment, behavioral and psychological symptoms of dementia (BPSD) are another im-
portant aspect ofmost dementia patients. This studywas designed for a new simple assessment of BPSD.We ﬁrst
employed a clinical survey for the local community with sending an inquiry letter to all members (n = 129) of
dementia caregiver society, and then attempted to create a new BPSD score for dementia with 10 BPSD items.
This new simple BPSD score was compared to a standard-detailed BPSD score neuropsychiatric inventory
(NPI) for a possible correlation (n=792) and a time to complete (n= 136). Inter-rater reliability was examined
comparing scores between main and second caregivers (n = 70) for AD. Based on the clinical survey for local
caregivers, a new BPSD score for dementia (ABS, Abe's BPSD score) was newly created, in which each BPSD
item was allotted by an already-weighted score (maximum 1–9) based on the frequency and severity, and was
ﬁnalized with taking temporal occurrences into account. ABS was ﬁlled by the main caregiver with a full score
of 44, was well correlated with NPI (r = 0.716, **p b 0.01) in 792 AD patients (age 78.6 ± 7.0 years, MMSE
19.0 ± 5.9), and took a shorter time as only 56.8 ± 38.8 s (**p b 0.01) than NPI score (132.7 ± 94.0 s) with
136 AD patients. A high inter-rater reliability was obtained (r = 0.964, **p b 0.01) with a little smaller score
(0.877 time) of ABS in secondary than the main caregivers. ABS provides a new simple and quick test for BPSD
assessment, with a good correlation to NPI but a shorter time, and with a high inter-rater reliability. Thus ABS
is useful for evaluating BPSD for mild to moderate dementia patients.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Dementia is an emerging problem not only in developed countries
but also in many developing countries including Asia [1]. Alzheimer's
disease (AD) occupies more than 60% of dementia in the developed
countries, followed by mild cognitive impairment (MCI), vasculardisease; ADAS-Cog, Alzheimer's
D, behavioral pathology in AD;
a; CDR, Clinical Dementia Rating
ChEI, choline esterase inhibitor;
turbance Scale; DLB, dementia
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tia Score—Revised;M,months;
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ia; WAIS-R, Wechsler Adult
.
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sity, 2-5-1 Shikatacho, Kitaku,
81 86 236 7368.
).
. This is an open access article underdementia (VaD), dementia with Lewy bodies (DLB), fronto-temporal
lobar dementia (FTLD), and other types of dementia. Dementia mainly
consisted of 2 neuropsychological problems, namely cognitive impair-
ment (CI) and affective-behavioral change. The latter is currently called
behavioral and psychological symptoms of dementia (BPSD).
There are a number of clinical scores to measure CI and BPSD for de-
mentia patients. Among them, mini-mental state examination (MMSE)
and Hasegawa Dementia Score-Revised (HDS-R) are common for
screening general cognitive function [2,3]. As for BPSD, behavioral
pathology in AD (Behave-AD) was proposed at year 1987 [4], Crichton
Geriatric Behavioral Rating Scale (CGBRS) at year 1989 [5,6], Dementia
Behavior Disturbance Scale (DBDS) at year 1990 [7], neuropsychiatric
inventory (NPI) at year 1994 [8], and Troublesome Behavior Scale
(TBS) at year 1994 [9]. Although these previous BPSD scores are well
established, all of them were designed for detailed examination and
thus usually take time.
Because the numbers of dementia patients are quickly increasing in
theworld, there is a strong need to evaluate BPSD as a quick test in daily
neurological/psychiatric or even general medicine clinics. However,
there has not been such a simple BPSD score for dementia patients.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Frequency (bottom) and severity (top) symptoms of 10 BPSD items obtained
from inquiry survey of 81 caregivers for dementia patients. Note the dissociation be-
tween the frequency and severity, especially in wandering in/outside home, apathy
and indifference, and high irritability.
Fig. 2. Plotting 10 BPSD items in the coordinate ﬁeld depending on their frequency and se-
verity, and 9 subﬁelds of the coordinate were allotted ranging 1–9 as maximum.
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munity, created a new simple BPSD score based on the survey results,
examined this new BPSD score for dementia patients in comparison to
NPI, and compared inter-rater reliability between main and secondary
caregivers.
2. Surveys and methods
We ﬁrst employed a clinical survey for the local community with
sending an inquiry letter to all members (n = 129) of the dementia
caregiver society in the Okayama Prefecture of Japan. The inquiry form
consisted of 10 items of main BPSD, namely, 1) wandering in/outside
home, 2) eating or toilet problem, 3) delusion or hallucination, 4) offen-
sive and abusive words, 5) day-night reversal, 6) excitation and agita-
tion, 7) apathy and indifference, 8) depressive and gloomy mood,
9) violent force, and 10) high irritability. In the inquiry, the caregiver
can choose any of 10 items if it is found in their patients for frequency,
and can choose up to 3 items as the most severe and troublesome
BPSD for severity.
Based on their returning inquiries, we analyzed the frequency and
severity of the 10 BPSD items in the dementia patients. We plotted
each BPSD item on a coordinate ﬁeld according to the frequency and se-
verity, and gave them already-weighted scores ranging 1–9 as maxi-
mum depending on the location of the coordinate ﬁeld that was
divided into 9 subﬁelds. Based on these initial scores, we gave a ﬁnal
grading score for each BPSD item depending on the temporal occur-
rence of the symptom ranging 0–9, and thus created a new BPSD
score sheet.
In order to examine a possible relationship between this new BPSD
score and a well established BPSD score NPI, both scores were simulta-
neously examined in 792 AD patients (age 78.6 ± 7.0 years old, MMSE
19.0±5.9,mean±SD) in our dementia clinics. A part of theADpatients
(n = 136) were also examined for the time to complete both this new
BPSD score and NPI. To assess the inter-rater reliability, this new BPSD
score was newly obtained from pair caregivers (main and secondary
caregivers) of 70 AD patients, and compared the scores for a possible
difference. Furthermore, MMSE was also examined for a possible rela-
tionship between this new BPSD score (891 AD patients plus MCI sub-
jects)/NPI (464 AD patients plus MCI subjects) and a standard
screening cognitive score MMSE.
Correlation analysis was performed by non-parametric Wilcoxon
Rank Sum test, and the data are expressed as mean ± SD. Data with
p b 0.05 were considered to be signiﬁcant. The present study was
approved by the Ethical Committee of Graduate School of Medicine,
Dentistry and Pharmaceutical Science, Okayama University (#694).
3. Results
Our ﬁrst inquiry survey collected 81 answers out of totally 129 let-
ters to main caregivers, showing 62.8% of returning rate. In the 81 an-
swers, the dementia patients receiving care were 81.6 ± 9.9 (mean ±
SD) years old in average (female rate 70.5%), and 50.0% of them were
being cared at home, 29.5% at nursing home or hospital, and 14.5% at
both (shuttling home and nursing home/hospital). The main caregivers
for the patients were 65.2 ± 11.5 years old in average (female rate
75.6%), who were consisted of 14.8% in husband, 24.4% in wife, 9.0% in
son, 25.6% in daughter, 7.7% in daughter-in-law, 3.8% in grandchild,
and 14.7% in others. Dementia patients consisted of 77% in AD, 8% in
VaD, 5% in DLB, 5% in FTLD, and 5% in mixed dementia (mixD) with an
average disease duration of 5 years.
As shown in Fig. 1, a frequency in each BPSD itemwas43.6%of eating
or toilet problem, 38.5% of wandering in/outside home, 38.5% of delu-
sion or hallucination, and so on (Fig. 1, bottom). On the other hand,
the most severe and troublesome BPSD items showed a different pat-
tern, such as 29.5% ofwandering in/outside home, 21.8% of eating or toi-
let problem, 16.7% of delusion or hallucination, and so on (Fig. 1, top).When the frequency and severity were plotted on a coordinate ﬁeld
according to their data, 7 items showed a slight correlation between the
frequency and severity, while 3 items (irritability, apathy, and wander-
ing) did not show such a trend of correlation (Fig. 2). After plotting
these 10 BPSD items on the coordinate ﬁeld, we divided the ﬁeld into
9 small subﬁelds and gave them initial scores ranging 1–9 as maximum
based on the frequency and severity (Fig. 2). After giving these initial
scores, we took temporal occurrences such as seldom (practically once
a year or less), occasionally (practically once amonth or so), sometimes
(practically once a week or so), and often (practically once a day or
more) into account as another important factor which affects the ﬁnal
scoring. Thus we gave ﬁnal scores to each BPSD item ranging 0–9, and
ﬁnally created a new BPSD score with ranging 0–44 from no BPSD
(score 0) to full BPSD (score 44) (Table 1).
Simultaneous examinations of this ABS and NPI for the main care-
givers of 792 AD patients in our dementia clinics showed a good corre-
lation between the ABS and NPI scores (Fig. 3) with a correlation
coefﬁcient of r=0.716 (**p b 0.01). Therewere almost no dementia pa-
tients showing the NPI score of more than 80 in our dementia clinics
Table 1
ABS score sheet.
Inquiry Seldom Occasionally Sometimes Often
1) Wandering in/outside home
2) Eating or toilet problem
0
0
3
3
6
6
9
9
3) Delusion or hallucination
4) Offensive & abusive words
5) Day–night reversal
0
0
0
2
2
2
4
4
4
6
6
6
6) Excitation & agitation
7) Apathy & indifference
8) Depressive & gloomy mood
9) Violent force
10) High irritability
0
0
0
0
0
1
0
0
0
0
2
1
0
0
0
3
2
1
1
1
Total score 44.
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score of 44 points (Fig. 3, vertical axis).
With another study of 136ADpatients in our dementia clinics, an av-
erage time to complete either NPI or ABS was 132.7 ± 94.0 s or 56.8 ±
38.8 s (**p b 0.01), respectively (Table 2). In the present study, the pa-
tients showed an NPI score of only less than 59 (49.2% of full score)
and an ABS score of up to 43 (97.7% of full score). Thus almost a full
score of ABS took only 42.8% of time for 49.2% of the NPI full score
(Table 2). AD patients with an NPI score of less than 10 still took up to
500 s, and those with an NPI score of more than 10 took even longer
duration of more than 600 s depending on the NPI score increase.
In terms of inter-rater reliability, the main caregivers for 70 AD pa-
tients (36 men and 34 women) consisted of husband (12.9%), wife
(42.1%), son (10.0%), daughter (12.9%), daughter-in-law (11.4%), and
professionals (5.7%). On the other hand, secondary caregiverswere hus-
band (2.9%), wife (0%), son (15.7%), daughter (24.3%), son-in-law
(1.4%), and professionals (41.4%). ABS was highly correlated between
the main and secondary caregivers with a correlation coefﬁcient of
r = 0.964 (**p b 0.01), but secondary caregivers got a little smaller
score (0.877 time) of ABS thanmain caregivers (Fig. 4).We further per-
formed “intra-rater reproducibility” with new 76 patients (mean age
77.2 ± 6.7 years old, male 43.4%) assessed by the same caregiver for a
baseline ABS and a repeated ABS at 1 week later, and found no signiﬁ-
cant change during the 1 week from baseline 4.8 ± 6.7 (mean ± SD)
to 1 week later 4.4 ± 6.5 (p = ns).
Correlations between the MMSE score and ABS/NPI score showed
that ABS represented 3–4 points in 891 AD patients plus MCI subjects
with an MMSE score of more than 20, which then increased toward
the peak of ABS 12 with a decreasing MMSE score to 6–10, and which
ﬁnally decreased again with a decreasing MMSE score below 5 (data
not shown). Similar pattern was observed in the NPI score with 46444
0
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S
Fig. 3. A good correlation between ABS and NPI scores in 792 AD patients (r = 0.716,
**p b 0.01), and no AD patients with NPI score more than 80 in spite of almost full
distribution in ABS ranging score 0–43.AD patients plus MCI subjects with the peak of NPI score 12 at MMSE
score 8 (data not shown).
4. Discussion
The present study proposed a new BPSD score for dementia (ABS,
Abe's BPSD score). This ABS is newly created based on the current status
of BPSD in a super-aged country Japan, is a score already allotted based
on the frequency and severity of each BPSD item ﬁnalized with taking
temporal occurrences into account (Table 1), is well correlated to NPI
(Fig. 3), but takes only 56.8 ± 38.8 s (42.8% of time for NPI scoring,
Table 2), shows a high inter-rater reliability (Fig. 4), and tends to corre-
late with MMSE. Thus ABS provides just a simple and quick test for
assessing BPSD in mild to moderate dementia patients.
Frequency and severity of BPSDmay be different among different ra-
cial, cultural and ethnic backgrounds, and evenmodernizing communi-
ty change. Such differences may be present between American/
Australian and Japanese/Chinese/Taiwan peoples [10–13]. Even within
the sameAsian people, there are considerable differences from the pres-
ent Japanese study in 1786 Korean AD patients with higher frequencies
of depression (50.6%), apathy (49.6%), irritation (42.0%) and aberrant
motor behavior (23.9%) measured with NPI (CREDOS study, ref. 14),
and in Shanghai Chinesewith higher frequencies of apathy and indiffer-
ence (62%), followed by agitation and aggression (54%), and hallucina-
tion (47%) [13]. Such a difference may also be present within
caregivers, where mainland-Chinese caregivers showed a higher
depression score followed by Australian-Chinese and Australian white
caregivers [15].
For evaluating BPSD, Behave-AD was ﬁrst proposed, and is charac-
terized by detailed scores for paranoid and delusion (7 items) and illu-
sion (5 items) [4]. CGBRS is characterized by 2 items formood problems
with either subjective or objective symptom [5,6], and is well correlated
to Zarit Caregiver Scale [16,17]. Because most DBDS items are positive
behavioral symptoms, this score does not well detect psychological
and negative behavioral symptoms [7]. The advantage of NPI is similar
to ABS (Table 1), where 10 items are already allotted and therefore
NPI is currently frequently used for BPSD evaluation in clinical trials
with 804 AD patients [8,18]. However, multiplication and summing-
up steps take time as shown in the present study (Table 2). TBS is a
relatively simple score, but all 15 items are for positive behavioral
symptoms and therefore misses psychological and negative behavioral
symptoms of BPSD [9].
In comparison to these previous scores, ABSmay be themost similar
to NPI especially in already allotted 10 items, and the good correlation ofTable 2
Time to complete ABS and NPI scoring in the same 136 AD patients.
NPI ABS p-Value
Time to complete scoring (s) 132.7 ± 94.0 56.8 ± 38.8 **p b 0.01
Range of the score (% of full score) 0–59 (49.2%) 0–43 (97.7%)
Full score 120 44
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Fig. 4. Plot of ABS betweenmain (x axis: horizontal) and secondary (y axis: vertical) care-
givers for 70 AD patients, showing a high correlation (r = 0.964, **p b 0.01) with a little
smaller ABS in secondary than main caregivers (y = 0.877x).
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ent from NPI in taking temporal occurrences into account (Table 1), in
different maximum scores already-weighted (scores 1–9), in no need
of multiplication, and thus in much shorter time to ﬁll out (Table 2)
which provides an advantage of ABS for screening BPSD. The dementia
patient with less than 20 points in NPI showed the wide variation of
ABS scores between 0 and 30 (Fig. 3). Because affective items are not ex-
actly the same between ABS and NPI, and also because the frequency
and severity are not again the same between ABS and NPI, there are
some variations between the scores. However, the coefﬁcient of r =
0.716 (**p b 0.01) may be a fair and acceptable correlation between
the similar but different scores (Fig. 3).
One interest is that there were almost no patients showing NPI of
more than 80 in our neurological dementia clinics (Fig. 3, horizontal
axis), where the same dementia patients showed almost a full range
of ABS from 0 to 43 (Fig. 3). Another interest is the high inter-rater reli-
ability and the smaller score of ABS in secondary than main caregivers
(Fig. 4). The high inter-rater reliability conﬁrms the usefulness of this
ABS, and the higher rate of professionals (41.4%)may account for a little
smaller score of ABS in secondary caregivers. The reason may be that
secondary caregivers (especially professionals) had more distance to
the patients than the primary caregivers (especially spouses), which
resulted in the small decrease of ABS in the secondary caregivers espe-
cially positive BPSD symptoms. Our intra-rater reproducibility also
suggested a reliability of ABS.
A limitation of the present study was mainly for mild to moderate
AD (MMSE 19.0 ± 5.9) but not severe AD who may show higher ABS
and NPI scores (Fig. 3). Thus the question is to be resolved in the future
whether if ABS is also useful for severe dementia patients who attend
more psychiatric clinics than neurological/general medicine clinics. An-
other limitation was that our ﬁrst cohort was not only for AD (77%), but
also for VaD (8%), DLB (5%), FTLD (5%) andmixed dementia (5%). How-
ever, our analysis showed a good correlation of the other type of demen-
tia toNPI, suggesting that this ABS could also be applied to other types of
dementia. On the other hand, BPSD score ranging 0–97.7% is still anoth-
er advantage of ABS for detecting andmonitoring BPSD formild tomod-
erate dementia. In summary, the present study proposes a new simpleand quick score (ABS) for assessing BPSD of mild to moderate AD and
other types of dementia [19,20]. ABS could also be useful for evaluating
a drug effect on BPSD after a therapeutic intervention in daily clinics.Disclosure
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